Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) Cash from Investing Activities Growth (3y) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -253.01%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -11.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -41.67%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -6.88%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -472.46%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -16.93%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -111.03%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -40.94%
10 Xtant Medical Holdings 64.46 Mn 47.14 Mn 17.75 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 125.78%
Jun 30, 2025 -7.67%
Mar 31, 2025 -42.98%
Dec 31, 2024 1.59%
Sep 30, 2024 -80.61%
Jun 30, 2024 -0.63%
Mar 31, 2024 -11.75%
Dec 31, 2023 -59.50%
Sep 30, 2023 -203.23%
Jun 30, 2023 -0.17%
Mar 31, 2023 -363.46%
Dec 31, 2022 -3.38%
Sep 30, 2022 -62.81%
Jun 30, 2022 -105.55%
Mar 31, 2022 -65.66%
Dec 31, 2021 -24.28%
Sep 30, 2021 -51.48%
Jun 30, 2021 -44.53%
Mar 31, 2021 -54.10%
Dec 31, 2020 -55.36%
Sep 30, 2020 24.50%
Jun 30, 2020 19.73%
Mar 31, 2020 17.35%
Dec 31, 2019 -12.80%
Sep 30, 2019 54.12%
Jun 30, 2019 26.47%
Mar 31, 2019 68.37%
Dec 31, 2018 -16.46%
Sep 30, 2018 26.06%
Jun 30, 2018 -93.08%
Mar 31, 2018 -59.79%
Dec 31, 2017 -8.84%
Sep 30, 2017 -56.45%
Jun 30, 2017 -132.55%
Mar 31, 2017 -154.26%
Dec 31, 2016 -74.88%
Sep 30, 2016 -180.54%
Jun 30, 2016 -145.00%
Mar 31, 2016 -78.53%
Dec 31, 2015 31.85%
Sep 30, 2015 -496.10%
Jun 30, 2015 65.39%
Mar 31, 2015 54.68%
Dec 31, 2014 34.43%
Sep 30, 2014 22.95%
Jun 30, 2014 26.54%
Mar 31, 2014 56.27%
Dec 31, 2013 49.40%
Sep 30, 2013 42.85%